Should obstructive hypopneas be included when analyzing sleep studies in infants with Robin Sequence?


Journal

Sleep medicine
ISSN: 1878-5506
Titre abrégé: Sleep Med
Pays: Netherlands
ID NLM: 100898759

Informations de publication

Date de publication:
10 2022
Historique:
received: 18 04 2022
revised: 02 06 2022
accepted: 09 06 2022
pubmed: 29 6 2022
medline: 10 8 2022
entrez: 28 6 2022
Statut: ppublish

Résumé

We have used an obstructive apnea index of ≥3 as treatment indication for infants with Robin sequence (RS), while the obstructive apnea-hypopnea index (OAHI) and a threshold of ≥5 is often used internationally. We wanted to know whether these two result in similar indications, and what the interobserver variability is with either asessement. Twenty lab-based overnight sleep recordings from infants with isolated RS (median age: 7 days, range 2-38) were scored based on the 2020 American Academy of Sleep Medicine guidelines, including or excluding obstructive hypopneas. Median obstructive apnea index (OAI) was 18 (interquartile range: 7.6-38) including only apneas, and 35 (18-54) if obstructive hypopneas were also considered as respiratory events (OAHI). Obstructive sleep apnea (OSA) severity was re-classified from moderate to severe for two infants when obstructive hypopneas were also considered, but this did not lead to a change in clinical treatment decisions for either infant. Median interobserver agreement was 0.86 (95% CI 0.70-0.94) for the OAI, and 0.60 (0.05-0.84) for the OAHI. Inclusion of obstructive hypopneas when assessing OSA severity in RS infants doubled the obstructive event rate, but impaired interobserver agreement and would not have changed clinical management.

Identifiants

pubmed: 35764010
pii: S1389-9457(22)01048-6
doi: 10.1016/j.sleep.2022.06.010
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

9-12

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Auteurs

Kathleen Lim (K)

Department of Neonatology and Pediatric Sleep Lab, Tübingen; University Children's Hospital, Tübingen, Germany; Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia.

Mirja Quante (M)

Department of Neonatology and Pediatric Sleep Lab, Tübingen; University Children's Hospital, Tübingen, Germany.

Tjeerd M H Dijkstra (TMH)

Department of Translational Bioinformatics, University of Tübingen, Tübingen, Germany; Department for Women's Health, University of Tübingen, Tübingen, Germany.

Gabriele Hilbert-Moessner (G)

Department of Neonatology and Pediatric Sleep Lab, Tübingen; University Children's Hospital, Tübingen, Germany; Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia.

Cornelia Wiechers (C)

Department of Neonatology and Pediatric Sleep Lab, Tübingen; Interdisciplinary Center for Cleft Palate and Craniofacial Malformations, Tübingen University Hospital, Tübingen, Germany.

Peter Dargaville (P)

Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia.

Christian F Poets (CF)

Department of Neonatology and Pediatric Sleep Lab, Tübingen; University Children's Hospital, Tübingen, Germany; Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia; Interdisciplinary Center for Cleft Palate and Craniofacial Malformations, Tübingen University Hospital, Tübingen, Germany. Electronic address: Christian-f.poets@med.uni-tuebingen.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH